Abstract
It is a time tested phenomenon that in spite of deadly toxins in snake venoms, they are used for curing certain ailments of human suffering. Historically this application appears to co-evolve in many countries where India has significant contribution. Before independence, few British surgeons and naturalists documented the profile of snakes in India and investigated their venoms. With the advancement of technology, it is now conclusively known that venoms are rich source of bioactive compounds that can be used for therapeutic purposes. Many venom components have been purified and their structures at molecular level have been derived. Since overproduction of peptides and proteins are now possible in vitro, venom components are likely to serve as templates or scaffold to provide information for developing drugs of discrete specificity and high potency. Venom components are used as diagnostic tool, e.g. Russell’s viper (Daboia russelli) venom factor V and X activator and ecarin from Saw scaled viper (Echis carinatus) venom for blood clotting test. Components from cobra (Naja naja) venom showed good results as chemotherapeutic agent in the clinical trials. In this review, the trend of investigations on snake venom in India from ancient time to modern period has been presented focusing on their therapeutic applications.
Keywords: Zootherapy, snake venom, Ayurveda, toxins, enzymes, non-enzyme toxins, pharmacotherapy.
Mini-Reviews in Organic Chemistry
Title:Therapeutic Use of Snake Venom Components: A Voyage from Ancient to Modern India
Volume: 11 Issue: 1
Author(s): Payel Bhattacharjee and Debasish Bhattacharyya
Affiliation:
Keywords: Zootherapy, snake venom, Ayurveda, toxins, enzymes, non-enzyme toxins, pharmacotherapy.
Abstract: It is a time tested phenomenon that in spite of deadly toxins in snake venoms, they are used for curing certain ailments of human suffering. Historically this application appears to co-evolve in many countries where India has significant contribution. Before independence, few British surgeons and naturalists documented the profile of snakes in India and investigated their venoms. With the advancement of technology, it is now conclusively known that venoms are rich source of bioactive compounds that can be used for therapeutic purposes. Many venom components have been purified and their structures at molecular level have been derived. Since overproduction of peptides and proteins are now possible in vitro, venom components are likely to serve as templates or scaffold to provide information for developing drugs of discrete specificity and high potency. Venom components are used as diagnostic tool, e.g. Russell’s viper (Daboia russelli) venom factor V and X activator and ecarin from Saw scaled viper (Echis carinatus) venom for blood clotting test. Components from cobra (Naja naja) venom showed good results as chemotherapeutic agent in the clinical trials. In this review, the trend of investigations on snake venom in India from ancient time to modern period has been presented focusing on their therapeutic applications.
Export Options
About this article
Cite this article as:
Bhattacharjee Payel and Bhattacharyya Debasish, Therapeutic Use of Snake Venom Components: A Voyage from Ancient to Modern India, Mini-Reviews in Organic Chemistry 2014; 11 (1) . https://dx.doi.org/10.2174/1570193X1101140402101043
DOI https://dx.doi.org/10.2174/1570193X1101140402101043 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
Call for Papers in Thematic Issues
Advancements in Synthesis of Bioactive Compounds
This thematic issue focuses on elucidating advanced synthetic strategies for bioactive compounds, with the primary objective of deepening understanding of the rational design and construction of target molecules. The exploration encompasses a diverse range of techniques, established name reactions, and cutting-edge synthetic methodologies. Specifically, the issue delves into the synthesis ...read more
Applications of Molecular Descriptors in Physicochemical Properties Research of Organic Compounds
Chemical graph theory is concerned with all aspects of the application of graph theory to various areas of chemistry, including organic, theoretical, mathematical, and computational chemistry, as well as in bioinformatics and computational biology. By the use of the term chemical it is emphasized that one is allowed in chemical ...read more
Navigating the 2D Universe in Organic Chemistry
This special issue explores the transformative impact of two-dimensional (2D) materials on the realm of organic chemistry, unraveling new possibilities for synthesis, functionalization, and applications of organic compounds. Focused on the unique chemistry within this novel dimension, the issue highlights breakthroughs in the field of 2D organic chemistry. Contributions are ...read more
Small Molecules, Big Impact: Pioneering Approaches in Anti-inflammatory Care
This thematic issue is dedicated to the latest advancements and research breakthroughs in the realm of anti-inflammatory pharmacotherapy. With inflammation playing a critical role in numerous chronic conditions such as cardiovascular diseases, diabetes, and autoimmune disorders, there is an urgent need for more targeted, effective, and safer anti-inflammatory treatments. This ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Impact of Hypothermia on the Pharmacokinetics of Drugs Used in Neonates and Young Infants
Current Pharmaceutical Design Inflammatory Markers in Hyperlipidemia: From Experimental Models to Clinical Practice
Current Pharmaceutical Design The Shift in the “Paradigm” of the Pharmacology of Hypertension
Current Topics in Medicinal Chemistry Phosphoinositide 3-Kinase Gamma (PI3Kγ) Inhibitors for the Treatment of Inflammation and Autoimmune Disease
Recent Patents on Inflammation & Allergy Drug Discovery Purinergic Signalling: What is Missing and Needed Next? The Use of Transgenic Mice, Crystallographic Analysis and MicroRNA
CNS & Neurological Disorders - Drug Targets Thrombotic Microangiopathies: Towards a Pathophysiology-Based Classification
Cardiovascular & Hematological Disorders-Drug Targets A Review of the Relationships Between Endogenous Sex Steroids and Incident Ischemic Stroke and Coronary Heart Disease Events
Current Cardiology Reviews The Role of Anti-LeY Antibody in the Downregulation of MAPKs/COX-2 Pathway in Gastric Cancer
Current Drug Targets Transient Receptor Potential (TRP) Channels and Cardiac Fibrosis
Current Topics in Medicinal Chemistry P-Selectin Antagonism in Inflammatory Disease
Current Pharmaceutical Design Editorial
Current Medical Imaging Cardiovascular Effects of Neuregulin-1/ErbB Signaling: Role in Vascular Signaling and Angiogenesis
Current Pharmaceutical Design Anti-Inflammatory Approaches that Target the Chemokine Network
Recent Patents on Inflammation & Allergy Drug Discovery Protective Effects of Anesthetics on the Spinal Cord
Current Pharmaceutical Design Ecto-Nucleotidase Inhibitors: Recent Developments in Drug Discovery
Mini-Reviews in Medicinal Chemistry Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Editorial [ Pharmacological Modulation of Liver Ischemia - Reperfusion Injury Executive Editors: G.K. Glantzounis, D.P. Mikhailidis, A.M. Seifalian and B.R. Davidson ]
Current Pharmaceutical Design Comprehensive Review on Custodiol-N (HTK-N) and its Molecular Side of Action for Organ Preservation
Current Pharmaceutical Biotechnology CCR1 and CCR2 Antagonists
Current Topics in Medicinal Chemistry Design, Synthesis and Biological Study of Novel NO-Donor-Caffeic Acid Hybrids as Potential Anti-Atherosclerotic Drug Candidates
Letters in Drug Design & Discovery